In December 2025, a headline most men never expected to see broke through the noise: an FDA expert panel recommended that testosterone should no longer be treated like a dangerous drug.
On December 10, 2025, the FDA convened a panel of urologists, endocrinologists, and men's health researchers to re-evaluate how testosterone replacement therapy (TRT) is regulated in the United States. The panel's conclusion was unanimous and sweeping: the rules that have governed testosterone since 1990 are outdated, not supported by modern evidence, and are actually contributing to undertreatment and unsafe gray-market workarounds.
For millions of American men experiencing symptoms of low testosterone, the moment felt significant. Testosterone has spent decades at a strange intersection of medicine, stigma, sports doping headlines, and internet hype.